Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients

Archives of Virology

Volumn 151, Issue 10, 2006, Pages 1899-1916

  Ravaggi, A ^a   Romani, C ^a   Pasinetti, B ^a   Tassi, R A ^a   Bignotti, E ^a   Bandiera, E ^a   Odicino, F E ^b   Ragnoli, M ^a   Donzelli, C ^b   Falchetti, M ^b   Calza, S ^a   Santin, A D ^a,c   Pecorelli, S ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Spedali Civili di Brescia ^*  (Italy)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BIOTIN; CANCER VACCINE; DNA BINDING PROTEIN; E7 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18; IMMUNOGLOBULIN G; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; PAPILLOMA VIRUS VACCINE; PROTEIN E7; RECOMBINANT PROTEIN; STREPTAVIDIN; VIRUS ANTIBODY; WART VIRUS VACCINE;

ANTIBODY SPECIFICITY; ARTICLE; BIOSYNTHESIS; BLOOD; CARCINOMA; COMPARATIVE STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOLOGY; METHODOLOGY; PRECANCER; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX TUMOR; VACCINATION;

ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; BIOLOGICAL MARKERS; BIOTIN; CANCER VACCINES; CARCINOMA; DISEASE PROGRESSION; DNA-BINDING PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; PAPILLOMAVIRUS VACCINES; PRECANCEROUS CONDITIONS; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; STREPTAVIDIN; UTERINE CERVICAL NEOPLASMS; VACCINATION;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 33748973203     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-006-0787-y     Document Type: Article

References (46)

1. MF Baay JM Duk MP Burger J Walboomers J ter Schegget KH Groenier HW de Bruijn E Stolz P Herbrink 1995 Antibodies to human papillomavirus type 16 E7 related to clinicopathological data in patient with cervical carcinoma J Clin Pathol 48 410 414
2. MFD Baay JM Duk MPM Burger HWA de Bruijn E Stolz P Herbrink 1995 Follow-up of antibody responses to human papillomavirus type 16 E7 in patients treated for cervical carcinoma J Med Virol 45 342 347
3. MFD Baay WGV Quint J Koudstaal H Hollema JM Duk MPM Burger E Stolz P Herbrink 1996 A comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by polymerase chain reaction in paraffin-embedded cervical carcinomas J Clin Microbiol 34 745 747
4. MF Baay JM Duk KH Groenier MP Burger HW de Bruijn H Hollema E Stolz P Herbrink 1997 Relation between HPV-16 serology and clinico-pathological data in cervical carcinoma patients: prognostic value of anti-E6 and/or anti-E7 antibodies Cancer Immunol Immunother 44 211 215
5. MFD Baay JM Duk MPM Burger HWA de Bruijn E Stolz P Herbrink 1999 Humoral immune response against proteins E6 and E7 in cervical carcinoma patients positive for human papilloma virus type 16 during treatment and follow-up Eur J Clin Microbiol Infect Dis 18 126 132
6. JJ Bartko 1966 The intraclass correlation coefficient as a measure of reliability Psychol Rep 19 3 11
7. LZ Bito 1977 Inflammatory effects of endotoxin-like contaminates in commonly used protein preparation Science 196 83 85
8. FX Bosh MM Manos N Munoz M Sherman AM Jansen J Peto MH Schiffman V Moreno R Kurman KV Shah 1995 Prevalence of human papillomavirus in cervical cancer: a worldwide perspective J Natl Cancer Inst 87 796 802
9. LA Brinton 1992 Epidemiology of cervical cancer: overview IARC Sci Publ 119 3 23
10. JE Butler L Ni R Nessler KS Joshi M Suter B Rosemberg J Chang WR Brown LA Cantarero 1999 The physical and functional behaviour of capture antibodies adsorbed on polystyrene J Immunol Methods 150 77 90
11. YH Chee SE Namkoong DH Kim SJ Kim JS Park 1995 Immunologic diagnosis and monitoring of cervical cancers using in vitro translated HPV proteins Gynecol Oncol 57 226 231
12. WF Cheng CN Lee YN Su MC Chang WC Hsiao CA Chen CY Hsieh 2005 Induction of human papillomavirus type 16-specific immunologic responses in a normal and an human papillomavirus-infected populations Immunology 115 136 149
13. A Clavijo EM Zhou S Vydelingum R Heckert 1998 Development and evaluation of a novel antigen capture assay for the detection of classical swine fever virus antigens Vet Micro 60 155 168
14. SA Darst CR Robertson JA Berzofsky 1988 Adsorption of the protein antigen myoglobin affects the binding of conformation-specific monoclonal antibodies Biophys J 53 533 539
15. A Di Lonardo ML Marcante F Poggiali A Venuti 1998 HPV 16 E7 antibody levels in cervical cancer patients: before and after treatment J Med Virol 54 192 195
16. A Ferrara M Nonn P Sehr C Schreckenberger M Pawlita M Durst A Schneider AM Kaufmann 2003 Dendritic cell-based tumor vaccine for cervical cancer II: results of a clinical pilot study in 15 individual patients J Cancer Res Clin Oncol 129 521 530
17. Y Fujinaga M Shimada K Okazawa M Fukuschima I Kato K Fujinaga 1991 Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction J Gen Virol 72 1039 1044
18. KN Gaarenstroom GG Kenter JM Bonfrer CM Korse MP Gallee AA Hart M Müller JB Trimbos TJ Helmerhorst 1994 Prognostic significance of serum antibodies to human papillomavirus-16 E4 and E7 peptides in cervical cancer Cancer 74 2307 2313
19. E Hamsikova V Ludvikova R Tachezy J Kovarik L Brouskova V Vonka 2000 Longitudinal follow-up of antibody response to selected antigens of human papillomaviruses and herpes viruses in patients with invasive cervical carcinoma Int J Cancer 86 3 351 355
20. KL Karem AC Poon C Bierl R Nisenbaum E Unger 2002 Optimization of human papillomavirus-specific enzyme-linked immunosorbent assay Clin Diagn Lab immunol 9 577 582
21. CJ Kim SJ Um ES Hwang SN Park SJ Kim SE Namkoong JS Park 1999 The antibody response to HPV proteins and the genomic state of HPVs in patients with cervical cancer Int J Gynecol Cancer 9 1 11
22. M Lehtinen A Leminen T Kuoppala M Tiikainen T Lehtinen P Lehtovirta R Punnonen E Vesterinnen J Paavonen 1992 Pre- and post-treatment serum antibody responses to HPV-16 E2 and HSV 2 ICP8 proteins in women with cervical carcinoma J Med Virol 37 180 196
23. P Lenner J Dillner F Wiklund G Hallmans U Stendahl 1995 Serum antibody responses against human papillomavirus in relation to tumor characteristics, response to treatment, and survival in carcinoma of the uterine cervix Cancer Immunol Immunother 40 201 215
24. S Liu R Tobias S McClure G Styba Q Shi G Jackowski 1997 Removal of endotoxin from recombinant protein preparations Clin Biochem 30 455 463
25. VM Mann S Loo de Lao M Brenes LA Brinton JA Rawls M Green WC Reeves WE Rawls 1990 Occurrence of IgA and IgG antibodies to select peptides representing human papillomavirus type 16 among cervical cancer cases and controls Cancer Res 50 7815 7819
26. W Meschede K Zumbach J Braspenning M Scheffner L Benitez-Bribiesca J Luande L Gissmann M Pawlita 1998 Antibodies against early proteins of human papillomaviruses as diagnostic markers for invasive cervical cancer J Clin Microbiol 36 475 480
27. DC Morrison RJ Ulevittch 1978 The effect of bacterial endotoxins on host mediated systems Am J Pathol 93 527 617
28. M Muller RP Viscidi Y Sun E Guerrero PM Hill F Shah FX Bosch N Munoz L Gissmann KV Shah 1992 Antibodies to HPV 16 E6 and E7 proteins as markers for HPV 16 associated invasive cancer Virology 187 508 514
29. M Muller RP Viscidi V Ulken JN Bavinck PM Hill SG Fisher R Reid N Munoz A Schneider KV Shah 1995 Antibodies to the E4, E6, and E7 proteins of human papillomavirus (HPV) type 16 in patients with HPV-associated diseases and in the normal population J Invest Dermatol 104 138 141
30. HH Nguyen TR Broker LT Chow RD Alvarez HL Vu J Andrasi LR Brewer G Jin J Mestecky 2005 Immune responses to human papillomavirus in genital tract of women with cervical cancer Gynecol Oncol 96 452 461
31. I Nindl L Benitez-Bribiesca J Berumen N Farmanara S Fisher G Gross L Lopez-Carillo M Müller M Tommasino A Vasquez-Curiel L Gissmann 1994 Antibodies against linear and conformational epitopes of the human papillomavirus (HPV) type 16 E6 and E7 oncoproteins in sera of cervical cancer patients Arch Virol 137 341 353
32. R Rosales M Lopez-Contreras RR Cortes 2001 Antibodies against human papillomavirus (HPV) type 16 and 18 E2, E6 and E7 protein in sera: correlation with presence of papillomavirus DNA J Med Virol 65 736 744
33. AD Santin PL Hermonat A Ravaggi M Chiriva-Internati DJ Zhan S Pecorelli GP Parham M Cannon 1999 Induction and characterization of human papillomavirus-specific cytotoxic T lymphocytes by E7 pulsed autologous dendritic cells in patients with HPV-16 and 18 positive cervical cancer J Virol 3 5402 5410
34. AD Santin S Bellone M Gokden MJ Cannon GP Parham 2002 Vaccination with HPV-18 E7-pulsed dendritic cells in a patient with metastatic cervical cancer N Engl J Med 346 1752 1753
35. T Sasagawa M Inoue O Tanizawa M Yutsudo A Hakura 1992 Identification of antibodies against human papillomavirus type 16 E6 and E7 proteins in sera of patients with cervical neoplasias Jpn J Cancer Res 83 705 713
36. RS Searle G Casella CE McCulloch 1992 Variance Components Wiley Chichester
37. P Sehr K Zumbach M Pawlita 2001 A generic capture ELISA for recombinant protein fused to glutathione S-transferase: validation for HPV serology J Immunol Methods 253 153 162
38. I Silins E Avall-Lundqvist A Tadesse KU Jansen U Stendahl P Lenner K Zumbach M Pawlita J Dillner B Frankendal 2002 Evaluation of antibodies to human papillomavirus as prognostic markers in cervical cancer patients Gynecol Oncol 85 333 338
39. KM Stone KL Karem MR Sternberg GM McQuillan AD Poon ER Unger WC Reeves 2002 Seroprevalence of human papillomavirus type 16 infection in the United States J Infect Dis 186 1396 1402
40. A Suchankova L Ritterova M Krcmar V Krchnak J Vagner I Jochmus L Gissmann J Kanka V Vonka 1991 Comparison of ELISA and western blotting for human papillomavirus type 16 E7 antibody determination J Gen Virol 72 2577 2581
41. Y Sun KV Shah M Muller N Munoz XF Bosch RP Viscidi 1994 Comparison of peptide enzyme-linked immunosorbent assay and radioimmunoprecipitation assay with in vitro-translated proteins for detection of serum antibodies to human papillomavirus type 16 E6 and E7 proteins J Clin Microbiol 32 2216 2220
42. MY Tjiong K Zumbach JT Schegget N van der Vange TA Out M Pawlita L Struyk 2001 Antibodies against human papillomavirus type 16 and 18 E6 and E7 proteins in cervicovaginal washings and serum of patients with cervical neoplasia Viral Immunol 14 415 424
43. RP Viscidi S Yeping B Tsuzaki FX Bosch N Munoz K Shah 1993 Serologic response in human papillomavirus-associated invasive cervical cancer Int J Cancer 55 780 784
44. TL Wang M Ling IM Shih T Pham SI Pai Z Lu RJ Kurman DM Pardoll TC Wu 2000 Intramuscular administration of E7-transfected dendritic cells generates the most potent E7-specific anti-tumor immunity Gene Therapy 7 726 733
45. EM Zhou J Riva A Clavjio 2001 Development of an immunoglobulin M (IgmM) capture enzyme-linked immunosorbent assay for the detection of equine and swine antibodies to vescicular stomatitis virus Clin Diag Lab Immunol 8 475 481
46. K Zumbach M Hoffmann T Kahn F Bosch S Gottschlich T Gorogh H Rudert M Pawlita 2000 Antibodies against oncoprotein E6 and E7 of uman papillomavirus 16 and 18 in patients with head-and-neck squamous-cell carcinoma Int J Cancer 85 815 818